| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
107 | 36 | - | ||||
Cost of revenue | ||||||
136 | 54 | - | ||||
Gross loss | ||||||
-29 | -18 | - | ||||
Operating expenses: | ||||||
Research and development | ||||||
9,013 | 6,048 | 4,262 | ||||
Sales and marketing | ||||||
4,897 | 4,312 | 2,415 | ||||
General and administrative | ||||||
9,497 | 8,547 | 6,287 | ||||
Total operating expenses | ||||||
23,407 | 18,907 | 12,964 | ||||
Operating loss | ||||||
-23,436 | -18,925 | -12,964 | ||||
Warrant expense | ||||||
- | 3,156 | - | ||||
Gain (loss) on change in estimated fair value of contingent royalty obligation | ||||||
-81 | 291 | 252 | ||||
Finance income, net | ||||||
273 | 103 | -6 | ||||
Other income | ||||||
- | 38 | - | ||||
Foreign currency loss | ||||||
-4 | -26 | 22 | ||||
Loss before income taxes | ||||||
-23,086 | -22,257 | -13,200 | ||||
Net loss | ||||||
-23,086 | -22,257 | -13,200 | ||||
Basic and diluted loss per common share | ||||||
-0.92 | -1.47 | -1.28 | ||||
Weighted average number of common shares outstanding, basic and diluted | ||||||
25,133 | 15,137 | 10,332 | ||||